Bolt Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BOLT for the last quarter is 2.09 M USD, and it's 17.37% lower compared to the previous quarter. The net income of Q4 23 is -17.90 M USD.